πŸ‡ΊπŸ‡Έ FDA
Patent

US 11459300

Deuterated compounds and uses thereof

granted A61KA61K31/47A61K45/06

Quick answer

US patent 11459300 (Deuterated compounds and uses thereof) held by Aldeyra Therapeutics, Inc. expires Mon Sep 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Aldeyra Therapeutics, Inc.
Grant date
Tue Oct 04 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/47, A61K45/06, A61P, A61P17/00